Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Kowa Co., Ltd. is a Japanese healthcare company specializing in pharmaceuticals and medical devices, with a strong presence in the cardiovascular and dermatological segments. The company differentiates itself through its proprietary drug formulations and a robust distribution network across Japan and select international markets.
Kowa generates revenue primarily through the sale of prescription pharmaceuticals, particularly in the cardiovascular and dermatology sectors, leveraging its proprietary research and development capabilities. The company benefits from strong pricing power due to its established brand reputation and the effectiveness of its products.
Regulatory approvals for new drug formulations
Market penetration of existing products in Asia-Pacific regions
Changes in healthcare policies affecting pharmaceutical pricing
Partnerships or collaborations with other pharmaceutical companies
Regulatory changes impacting drug pricing and approval processes
Technological disruption in drug development and delivery methods
Increased competition from generic drug manufacturers
Emerging biotech firms with innovative therapies
Low liquidity risk due to a strong current ratio of 3.01
Potential risks associated with future R&D investments
moderate - Kowa's performance is somewhat tied to healthcare spending, which can be influenced by GDP growth and consumer spending patterns.
Low - Kowa's low debt levels (Debt/Equity of 0.05) minimize the impact of rising interest rates on financing costs, although higher rates could affect consumer spending on healthcare products.
minimal - The company operates with low leverage, reducing sensitivity to credit market fluctuations.
growth - Investors may be drawn to Kowa's potential for revenue growth through new product launches and market expansion.
moderate - Historical volatility is relatively stable, reflecting the company's established market position.
